First Mercantile Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $243K | Sell |
3,145
-249
| -7% | -$19.6K | 0.03% | 342 |
|
|
2021
Q2 | $283K | Sell |
3,394
-293
| -8% | -$23.2K | 0.03% | 305 |
|
|
2021
Q1 | $278K | Buy |
3,687
+1,027
| +39% | +$83.9K | 0.03% | 318 |
|
|
2020
Q4 | $233K | Sell |
2,660
-380
| -13% | -$30.1K | 0.03% | 366 |
|
|
2020
Q3 | $228K | Sell |
3,040
-4,363
| -59% | -$441K | 0.03% | 366 |
|
|
2020
Q2 | $913K | Buy |
7,403
+54
| +0.7% | +$5.37K | 0.11% | 106 |
|
|
2020
Q1 | $621K | Buy |
7,349
+92
| +1% | +$7.93K | 0.09% | 130 |
|
|
2019
Q4 | $614K | Sell |
7,257
-141
| -2% | -$10.7K | 0.07% | 179 |
|
|
2019
Q3 | $499K | Sell |
7,398
-718
| -9% | -$55.3K | 0.05% | 240 |
|
|
2019
Q2 | $695K | Buy |
8,116
+206
| +3% | +$17.6K | 0.07% | 150 |
|
|
2019
Q1 | $703K | Sell |
7,910
-1,799
| -19% | -$167K | 0.17% | 145 |
|
|
2018
Q4 | $826K | Buy |
9,709
+1,696
| +21% | +$161K | 0.2% | 120 |
|
|
2018
Q3 | $777K | Buy |
8,013
+99
| +1% | +$9.88K | 0.15% | 155 |
|
|
2018
Q2 | $745K | Buy |
7,914
+1,553
| +24% | +$136K | 0.15% | 159 |
|
|
2018
Q1 | $516K | Buy |
6,361
+89
| +1% | +$7.64K | 0.11% | 242 |
|
|
2017
Q4 | $559K | Sell |
6,272
-596
| -9% | -$51.8K | 0.11% | 231 |
|
|
2017
Q3 | $639K | Sell |
6,868
-253
| -4% | -$22.4K | 0.12% | 226 |
|
|
2017
Q2 | $647K | Sell |
7,121
-1,908
| -21% | -$174K | 0.12% | 217 |
|
|
2017
Q1 | $793K | Sell |
9,029
-830
| -8% | -$73.8K | 0.12% | 199 |
|
|
2016
Q4 | $817K | Buy |
9,859
+2,459
| +33% | +$211K | 0.13% | 197 |
|
|
2016
Q3 | $685K | Sell |
7,400
-1,550
| -17% | -$146K | 0.09% | 301 |
|
|
2016
Q2 | $696K | Hold |
8,950
| – | – | 0.09% | 319 |
|
|
2016
Q1 | $738K | Sell |
8,950
-2,120
| -19% | -$172K | 0.09% | 287 |
|
|
2015
Q4 | $1.16M | Buy |
11,070
+700
| +7% | +$73.1K | 0.12% | 212 |
|
|
2015
Q3 | $1.09M | Buy |
10,370
+83
| +0.8% | +$11.1K | 0.11% | 245 |
|
|
2015
Q2 | $1.41M | Buy |
10,287
+900
| +10% | +$112K | 0.12% | 208 |
|
|
2015
Q1 | $1.17M | Buy |
9,387
+7,943
| +550% | +$842K | 0.1% | 274 |
|
|
2014
Q4 | $131K | Sell |
1,444
-131
| -8% | -$10.9K | 0.01% | 773 |
|
|
2014
Q3 | $114K | Buy |
1,575
+65
| +4% | +$4.27K | 0.01% | 846 |
|
|
2014
Q2 | $94K | Hold |
1,510
| – | – | 0.01% | 829 |
|
|
2014
Q1 | $103K | Sell |
1,510
-300
| -17% | -$22.1K | 0.01% | 906 |
|
|
2013
Q4 | $127K | Hold |
1,810
| – | – | 0.01% | 812 |
|
|
2013
Q3 | $131K | Sell |
1,810
-600
| -25% | -$39.9K | 0.01% | 809 |
|
|
2013
Q2 | $134K | Buy |
+2,410
| New | +$150K | 0.01% | 834 |
|
Other funds holding BMRN
BBA
First Mercantile Trust's BMRN Position: Q3 2021 in Review
First Mercantile Trust reduced its BioMarin Pharmaceuticals (BMRN) stake by 7.3% in Q3 2021, selling an estimated $19.6K and leaving 3,145 shares worth $243K. The position accounts for 0.03% of the portfolio, ranked #342.
First Mercantile Trust first reported a position in BMRN in Q2 2013 and has held it in 34 quarters since. The position peaked at $1.41M in Q2 2015. 511 funds tracked by Wall St. Rank hold BMRN as of Q3 2021.
- First Mercantile Trust held 3,145 shares of BioMarin Pharmaceuticals worth $243K as of Q3 2021.
- First Mercantile Trust sold 249 BioMarin Pharmaceuticals shares in Q3 2021, an estimated $19.6K.
- BioMarin Pharmaceuticals made up 0.03% of First Mercantile Trust's portfolio in Q3 2021, its #342 holding.
- First Mercantile Trust first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 34 quarters since.
- First Mercantile Trust's BioMarin Pharmaceuticals position peaked at $1.41M in Q2 2015.
- 511 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2021.
Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.